27.07.2013 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

were collected from TK animals at designated time points on GD 6 and 17 in rats<br />

and GD 6 and 18 in rabbits. On GD 20 or GD 29 maternal and developmental parameters<br />

were evaluated and in rats, fetal exposure was assessed on GD 20. No maternal<br />

and developmental toxicity was observed at any <strong>of</strong> the dose levels used in the<br />

rat study. Evidence <strong>of</strong> fetal exposure was determined in fetal plasma with mean fetal<br />

concentrations <strong>of</strong> PPD10558 and the metabolite (PPD11901) found to be between<br />

1% and 6% <strong>of</strong> the mean maternal concentrations. In rabbits, marked maternal<br />

toxicity including mortality (8 deaths; 1 doe at 25 and 7 at 50 mg/kg/day),<br />

abortions (2 at 25 mg/kg/day and 6 at 50 mg/kg/day) and reduction in gestation<br />

body weight, gestation body weight changes and decreased food consumption were<br />

observed. In addition, fetal body weights <strong>of</strong> the combined sexes were significantly<br />

reduced at 50 mg/kg/day in comparison to the controls. Based on a human dose <strong>of</strong><br />

80 mg BID the margins <strong>of</strong> exposure for teratogenic effects are at least 19x and 6x<br />

for rats and rabbits, respectively, based on the top doses <strong>of</strong> 320 mg/kg/day for rats<br />

and 50 mg/kg/day for rabbits. In conclusion, these studies show no evidence <strong>of</strong> teratogenicity<br />

<strong>of</strong> PPD10558 in both rats and rabbits, though overt maternal toxicity<br />

occurred in rabbits.<br />

1631 FOXQ1: A BRIDGE BETWEEN THE AHR AND<br />

HEDGEHOG SIGNALING PATHWAYS.<br />

A. Planchart. Mount Desert Island Biological Laboratory, Salisbury Cove, ME.<br />

<strong>The</strong> aryl hydrocarbon receptor (AHR) pathway has been <strong>of</strong> particular interest in<br />

studying the effects <strong>of</strong> environmental exposures on development because this pathway<br />

functions as an “antennae”, receiving input from the external environment that<br />

leads to changes in gene expression. Toxicant activation <strong>of</strong> the AHR pathway leads<br />

to crani<strong>of</strong>acial defects in model organisms including the zebrafish and mouse that<br />

are similar in pathology to some human crani<strong>of</strong>acial abnormalities. <strong>The</strong> hedgehog<br />

signaling pathway, a critical pathway required for the development <strong>of</strong> the vertebrate<br />

head and face and implicated in several human crani<strong>of</strong>acial disorders, is misregulated<br />

as a result <strong>of</strong> AHR pathway activation yet how this occurs is currently unknown.<br />

Our lab was the first to identify foxq1l, an evolutionarily conserved forkhead<br />

box transcription factor in zebrafish, as a target <strong>of</strong> the dioxin-activated AHR<br />

pathway. Foxq1l is activated by dioxin exposure in the zebrafish head, particularly<br />

in embryonic structures that give rise to the upper and lower jaw. We hypothesized<br />

that the AHR pathway links environmental exposures to crani<strong>of</strong>acial birth defects<br />

by misregulating the hedgehog signaling pathway via an intermediary signaling<br />

molecule, possibly foxq1l. We now demonstrate that misexpressing foxq1l leads to<br />

misregulation <strong>of</strong> the hedgehog pathway and abnormal crani<strong>of</strong>acial chondrogenesis,<br />

and consequently to abnormal head development in affected embryos, supporting<br />

the hypothesis that foxq1l functions as a bridge between the AHR and hedgehog<br />

signaling pathways. We propose that this mechanism is conserved in all vertebrates.<br />

1632 CLEFT PALATE IN RATS TREATED WITH A<br />

COMPOUND THAT HAS STEROL ANTISYNTHESIS<br />

ACTION.<br />

N. Ikemi 1 , T. Oota 2 and K. Kawashima 2 . 1 Otsuka AgriTechno Co., Ltd.,<br />

Tokushima, Japan and 2 Mitsubishi Chemical Medience Co., Ltd., Kumamoto, Japan.<br />

[Objective] We have been conducting experiments to investigate the mode <strong>of</strong> occurrence<br />

<strong>of</strong> cleft palate. <strong>The</strong> present experiments were designed to specify the period<br />

<strong>of</strong> sensitivity to a compound with a sterol synthesis inhibition action in induction<br />

<strong>of</strong> cleft palate in SD rats and to determine whether induction <strong>of</strong> cleft palate<br />

was due to the parent compound or its metabolite following amniotic fluid administration<br />

<strong>of</strong> this compound.<br />

[Methods] (Experiment 1) To identify its cleft palate induction action, forced oral<br />

administration <strong>of</strong> the compound to the animals was conducted once daily for 10<br />

days from the 6th day to 15th day <strong>of</strong> pregnancy (vaginal plug confirmation day: day<br />

0 <strong>of</strong> pregnancy). <strong>The</strong> doses were set at 15, 20 and 25 mg/kg. <strong>The</strong> animals underwent<br />

cesarean section on day 20 <strong>of</strong> pregnancy. (Experiment 2) To identify the critical<br />

period for the occurrence <strong>of</strong> cleft palate, a single dose (100 mg/kg) <strong>of</strong> the compound<br />

was administered to dams, and the animals underwent cesarean section on<br />

day 20 <strong>of</strong> pregnancy. (Experiment 3) To investigate whether the induction <strong>of</strong> cleft<br />

palate following administration <strong>of</strong> the compound was caused by the compound itself<br />

or by its metabolite, the abdomens <strong>of</strong> the dams were incised, and the compound<br />

was administered into the amniotic fluid through the uterine wall. Results]<br />

(Experiment 1) <strong>The</strong> incidences <strong>of</strong> cleft palate were 11%, 43% and 76% in the 15,<br />

20 and 25 mg/kg groups, respectively. (Experiment 2) <strong>The</strong> occurrence <strong>of</strong> cleft<br />

palate was observed following administration <strong>of</strong> every single dose on days 10, 11,<br />

12 and 13 <strong>of</strong> gestation. Based on a comparison <strong>of</strong> the incidences <strong>of</strong> cleft palate, the<br />

critical period for the occurrence <strong>of</strong> cleft palate was considered to be the day 13 <strong>of</strong><br />

gestation. (Experiment 3) No cleft palate was observed. [Conclusion] It was possible<br />

that metabolites <strong>of</strong> the compound induced cleft palate as cleft palate occurred<br />

frequently in fetuses <strong>of</strong> dams receiving an oral dose <strong>of</strong> the compound, while it was<br />

not observed in fetuses given the compound via the intraamniotic route.<br />

1633 CHEMICAL FORM MATTERS: DIFFERENTIAL<br />

ACCUMULATION OF ORGANIC AND INORGANIC<br />

MERCURY IN ZEBRAFISH LARVAE.<br />

T. C. MacDonald, M. Korbas, I. J. Pickering, G. N. George and P. H. Krone.<br />

University <strong>of</strong> Saskatchewan, Saskatoon, SK, Canada.<br />

Mercury is found in both organic and inorganic forms in the atmosphere, in sediment<br />

and in water bodies due to natural and anthropogenic sources. Limited information<br />

is available on the uptake and accumulation <strong>of</strong> Hg in developing organisms,<br />

particularly as it relates to chemical form <strong>of</strong> the metal. To address this problem we<br />

utilized synchrotron x-ray fluorescence imaging in zebrafish (Danio rerio), an increasingly<br />

well studied model vertebrate for investigating mechanisms <strong>of</strong> chemical<br />

toxicity. Zebrafish larvae were exposed to one <strong>of</strong> four forms <strong>of</strong> mercury (methyl<br />

mercury chloride, methyl mercury L-cysteine, mercuric chloride, and mercury bis-<br />

L-cysteineate). Adjacent serial sections were utilized for synchrotron imaging and<br />

histological staining, respectively. Sections were imaged using the X-ray fluorescence<br />

imaging technique on beamline 20-ID at the Advanced Photon Source (APS)<br />

in Argonne, IL. Significant variations in mercury accumulation were found in fish<br />

exposed to organic mercury as compared to fish exposed to inorganic mercury.<br />

Larvae exposed to inorganic mercury exhibited accumulation in the ventricular region<br />

<strong>of</strong> the brain. However, only the fish exposed to organic mercury exhibited accumulation<br />

in the lens epithelium, gut tube, and skeletal muscles. <strong>The</strong>se variations<br />

demonstrate the importance <strong>of</strong> considering chemical form when considering the<br />

uptake and accumulation <strong>of</strong> mercury. Ongoing research will investigate the efficacy<br />

<strong>of</strong> chelating agents. Although dimercaptosuccinic acid (DMSA) is not a true chelator<br />

it is currently used to treat mercury exposure. As DMSA is poorly optimized for<br />

this role it is not always effective. Other sequestration agents <strong>of</strong> interest are Nacetylcysteine<br />

(NAC) and alpha lipoic acid (ALA). Eventually, we hope to design<br />

and test a custom chelator that can bind and excrete different forms <strong>of</strong> mercury<br />

more effectively.<br />

1634 ABERRANT LIGAND-INDUCED ACTIVATION OF G-<br />

PROTEIN-COUPLED ESTROGEN RECEPTOR 1 (GPER)<br />

RESULTS IN DEVELOPMENTAL MALFORMATIONS<br />

DURING VERTEBRATE EMBRYOGENESIS.<br />

B. S. Jayasinghe and D. C. Volz. Department <strong>of</strong> Environmental Health Sciences,<br />

Arnold School <strong>of</strong> Public Health, University <strong>of</strong> South Carolina, Columbia, SC.<br />

G-protein-coupled estrogen receptor 1 (GPER) – a GPCR unrelated to nuclear estrogen<br />

receptors (ERs) but strongly activated by estradiol in both mammals and fish<br />

– is expressed and functional in numerous vertebrate organ systems and has been<br />

implicated as a potential target for xenoestrogen-mediated signaling in reproductive<br />

organs and tumors. To date, the distribution and functional characterization <strong>of</strong><br />

GPER within vertebrate organs have been restricted to juvenile and adult animals.<br />

In contrast, virtually nothing is known about the spatiotemporal distribution and<br />

function <strong>of</strong> GPER during vertebrate embryogenesis. Using zebrafish as an animal<br />

model, the aim <strong>of</strong> this study was to assess the functional role <strong>of</strong> GPER during embryogenesis.<br />

RT-PCR and whole mount in situ hybridization data suggest that<br />

GPER mRNA is expressed as early as 1-hr post-fertilization (hpf) and is strongly localized<br />

in the central nervous system. Continuous exposure to a selective GPER agonist<br />

(G-1) from 8 to 96 hpf resulted in dose-dependent effects on survival and<br />

gross larval morphology, including decreased body length, tail abnormalities, and<br />

axial curvature. However, exposure to a selective GPER antagonist (G-15) resulted<br />

in no discernible effects on survival or gross larval morphology. Importantly, based<br />

on co-exposure studies with G-1 and G-15, G-15 fully blocked G-1-induced morphologic<br />

effects, suggesting that G-1-induced effects are mediated via aberrant activation<br />

<strong>of</strong> GPER. Using reverse genetics (morpholino-based) strategies, we are currently<br />

testing whether (1) GPER knockdown alone results in developmental<br />

abnormalities and (2) translation <strong>of</strong> GPER (or other ERs) is required for G-1-induced<br />

effects on gross larval morphology. Overall, our findings suggest that aberrant<br />

ligand-induced GPER activation represents a potentially novel and understudied<br />

mode-<strong>of</strong>-action for environmentally relevant chemicals that affect vertebrate<br />

embryogenesis.<br />

1635 PRENATAL BISPHENOL-A ALTERS LUNG EPITHELIAL<br />

SECRETORY CELL MATURATION.<br />

S. Murphy, M. Boetticher, C. VandeVoort and L. Van Winkle. California<br />

National Primate Research Center, UC Davis, Davis, CA.<br />

Bisphenol-A (BPA) is used in the production <strong>of</strong> polycarbonate plastics. We hypothesized<br />

that exposure to BPA can disrupt fetal lung development because both airway<br />

and alveolar development occur in the prenatal period. To test this hypothesis<br />

we exposed timed pregnant Rhesus macaques to BPA. <strong>The</strong>re were 3 exposure<br />

SOT 2011 ANNUAL MEETING 351

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!